Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Tiziana set to study nasally administered foralumab for treatment of COVID-19

Sep. 17, 2020

TFF reports topline safety data from phase I study of voriconazole inhalation powder

Sep. 17, 2020

New target identified for ZIKV-induced microcephaly

Sep. 17, 2020

Phase I data for coadministered hookworm vaccine candidates, Na-GST-1 and Na-APR-1

Sep. 17, 2020

Lilly reports interim phase II data on SARS-CoV-2 neutralizing antibody LY-CoV555

Sep. 16, 2020

Innovation Pharmaceuticals reports new in vitro data on use of brilacidin for COVID-19

Sep. 16, 2020

Grant supports Melior's evaluation of tolimidone for COVID-19

Sep. 16, 2020

Arbutus presents continued positive data from first-in-human study of AB-729

Sep. 16, 2020

Prion protein's positive point

Sep. 16, 2020

Cyxone plans to study rabeximod in phase II trial for COVID-19

Sep. 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...